MAPT and Cognitive impairment: The central purpose of this investigation was to determine if either the AT8 or PHF1 phospho-tau epitopes, when displayed on Qβ VLPs, would be efficacious in generating targeted antibody responses, reducing tau pathology, and rescuing cognitive deficits in the rTg4510 model of tauopathy.